Clinical Trials Logo

Peripheral Vascular Diseases clinical trials

View clinical trials related to Peripheral Vascular Diseases.

Filter by:

NCT ID: NCT01279642 Completed - Clinical trials for Peripheral Vascular Disease

Placement of Peripherally Inserted Central Venous Catheters (PICC) in Children Guided by Ultrasound

Start date: August 2008
Phase: N/A
Study type: Interventional

Aimed to compare the success in the peripheral intravenous puncture (PIP), progression and placement of PICC in children, according to the use of Doppler vascular ultrasound (DVUS) or traditional method; to identify the influence of the DUVS in the time expended to PICC placement. Methods: Clinical, randomized and controlled trial conducted after ethical merits of research endorsement and the obtaining of consent for those responsible for the children. The sample, calculated in 42 PICC to obtain a power of 0,85, was distributed randomly into two groups, experimental group (EG) and controlled group (CG). To the statistical analyzes Pearson Chi-square, Fisher's Exact Tests, Generalization of Fischer's Exact and Mann-Whitney tests was applied (5%). Of the 42 catheters, 21 (50.0%) were implemented in EG and 21 (50.0%) in CG. The PIP was obtained in the first attempt in 90.5% of the punctures of the EG and in 47.6% of the GC, (p=0.003). PICC were implanted successfully in 18 (85.7%) children of GE and 11 (61.1%) of CG (p = 0.019). The median of the time spent to the procedure was significantly higher (p=0.001) in CG (50 minutes) when compared to EG (median 20 minutes).

NCT ID: NCT01273623 Completed - Clinical trials for Peripheral Arterial Disease

The Jetstream G3™ Calcium Study

Start date: January 2011
Phase: Phase 4
Study type: Interventional

To investigate the treatment effects with the Jetstream G3 System in moderate to severely calcified peripheral artery disease in the common femoral, superficial femoral or popliteal arteries using intravascular ultrasound (IVUS).

NCT ID: NCT01263665 Completed - Clinical trials for Peripheral Vascular Diseases

Evaluation of the 25 Centimeter (cm) GORE® VIABAHN® Endoprosthesis

Start date: December 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to confirm the safety and performance of the 25 cm GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface when used in the Superficial Femoral Artery.

NCT ID: NCT01256320 Completed - Clinical trials for Peripheral Arterial Disease

Egg Study With Peripheral Arterial Disease

Start date: June 2010
Phase: N/A
Study type: Interventional

The current research study has the potential to generate data that would provide solid clinical endpoints as to the impact of including eggs in a regular diet in individuals with peripheral arterial disease. Any one of three potential outcomes may be observed as a result of this study, and they are predicted as follows: 1) Egg consumption does not lead to a deterioration of indices of cardiovascular health; 2) Egg consumption improves indices of cardiovascular health; 3) Egg consumption worsens the indices of cardiovascular health.

NCT ID: NCT01250275 Completed - Clinical trials for Peripheral Arterial Disease

Effects of Canola Oil on Blood Vessel Function in Peripheral Arterial Disease

Start date: September 2011
Phase: N/A
Study type: Interventional

The fatty acid composition of canola oil will have beneficial acute and chronic effects on vascular function in individuals with peripheral arterial disease.

NCT ID: NCT01245335 Completed - Clinical trials for Critical Limb Ischemia

Bone Marrow Aspirate Concentrate (BMAC) for Treatment of Critical Limb Ischemia (CLI)

Start date: May 2011
Phase: Phase 3
Study type: Interventional

Critical Limb Ischemia prevents the legs and feet from receiving oxygen and nutrients needed for proper function. This severe lack of blood flow can lead to painful legs while walking or at rest and can result in foot sores, ulcers, gangrene, and even amputation. The purpose of this study is to determine if injections of concentrated bone marrow into damaged tissues will result in improved blood flow. If successful, this treatment could improve blood flow to the lower limb, reduce pain, and reduce the frequency of limb amputations.

NCT ID: NCT01241747 Completed - Clinical trials for Peripheral Artery Disease

Exercise for Women With Peripheral Arterial Disease

Start date: July 2009
Phase: N/A
Study type: Interventional

Hypothesis #1. Supervised exercise rehabilitation will result in greater increases in exercise performance, peripheral vascular function, and health-related quality of life than compared to the attention-control group. Hypothesis #2. The change in peripheral vascular function will be predictive of improved exercise performance following the supervised exercise program.

NCT ID: NCT01224600 Completed - Clinical trials for Peripheral Arterial Disease

EValuation of Systemic Atherothrombosis in Patients With ARTerial Disease of the Lower Limbs

EVART
Start date: January 2008
Phase: N/A
Study type: Observational

The purpose of this study is to determine the prevalence and risk factors, at the time of the diagnosis of PAD, for asymptomatic carotid stenosis and abdominal aortic aneurysm.

NCT ID: NCT01211028 Completed - Clinical trials for Cardiovascular Diseases

Adipose CELL Derived Regenerative Endothelial Angiogenic Medicine

ACELLDREAM
Start date: January 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The main purpose of this study is to evaluate the safety and feasibility of regenerative therapy with expanded adipose derived stroma/stem cells sue, administered intramuscularly in patients with critical leg ischemia.

NCT ID: NCT01188824 Completed - Ischemic Stroke Clinical Trials

The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study)

Start date: September 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate the Safety and Efficacy of Cilostazol in slowing down the progression of peripheral arterial disease (PAD) in ischemic stroke patients with PAD in Taiwan.